Product NDC: | 16590-891 |
Proprietary Name: | LANSOPRAZOLE |
Non Proprietary Name: | LANSOPRAZOLE |
Active Ingredient(s): | 30 mg/1 & nbsp; LANSOPRAZOLE |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, DELAYED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 16590-891 |
Labeler Name: | STAT Rx USA LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020406 |
Marketing Category: | NDA AUTHORIZED GENERIC |
Start Marketing Date: | 20091111 |
Package NDC: | 16590-891-60 |
Package Description: | 60 CAPSULE, DELAYED RELEASE in 1 BOTTLE (16590-891-60) |
NDC Code | 16590-891-60 |
Proprietary Name | LANSOPRAZOLE |
Package Description | 60 CAPSULE, DELAYED RELEASE in 1 BOTTLE (16590-891-60) |
Product NDC | 16590-891 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | LANSOPRAZOLE |
Dosage Form Name | CAPSULE, DELAYED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20091111 |
Marketing Category Name | NDA AUTHORIZED GENERIC |
Labeler Name | STAT Rx USA LLC |
Substance Name | LANSOPRAZOLE |
Strength Number | 30 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA] |